Clinical trials
Withdrawn Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
76 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 76 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Maryland, Baltimore | 4 |
| Beersheva Mental Health Center | 3 |
| NYU Langone Health | 3 |
| University of British Columbia | 3 |
| VA Office of Research and Development | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Centre for Addiction and Mental Health | 2 |
| Hôpital le Vinatier | 2 |
| Massachusetts General Hospital | 2 |
| Seoul National University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 76 |
| Psychotic Disorders | 22 |
| Bipolar Disorder | 6 |
| Major Depressive Disorder | 3 |
| Mental Disorders | 3 |
| Tobacco Use Disorder | 3 |
| Cognitive Dysfunction | 2 |
| Inflammation | 2 |
| Tardive Dyskinesia | 2 |
| Attention Deficit Disorder with Hyperactivity | 1 |
Trials
Showing 26 to 50 of 76. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.